Health Care & Life Sciences » Pharmaceuticals | Boryung Pharmaceutical Co. Ltd.

Boryung Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Boryung Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Small Cap Series
251,820
0.56%
0
0.03%
01/31/2018
Government Pension Fund - Global (The)
242,900
0.55%
-225,890
0%
12/31/2017
Mirae Asset TIGER Momentum ETF
220,445
0.5%
220,445
13.75%
04/30/2018
Mirae Asset TIGER Health Care ETF
202,346
0.46%
170,096
1.3%
04/30/2018
Mirae Asset TIGER Consumer Staples ETF
147,872
0.34%
97,152
0.75%
04/30/2018
DFA Emerging Markets Core Equity Portfolio
108,705
0.25%
0
0%
04/30/2018
Mirae Asset TIGER 200
92,360
0.21%
23,340
0.03%
01/31/2018
42,048
0.1%
32,658
4.03%
04/30/2018
SPDR S&P International Small Cap ETF
19,351
0.04%
0
0.02%
09/06/2018
Amundi Funds - Equity Korea
16,580
0.04%
16,580
0.5%
01/31/2018

About Boryung Pharmaceutical Co.

View Profile
Address
Boryung Building
Seoul SL 03127
Korea, Republic Of
Employees -
Website http://www.boryung.co.kr
Updated 07/08/2019
Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.